verified
SJR 0,971 · Q2
•
database
Scopus / SJR indexed
United Kingdom · Elsevier Ltd
workspace_premium
Q2 — Oncology
lock
Subscription
Cancer Treatment and Research Communications
Cancer Treatment and Research Communications is a journal indexed in SJR in Oncology and Cancer Research with an H index of 29. It has an SJR impact factor of 0,971 and it has a best quartile of Q2. It has an SJR impact factor of 0,971.
Publisher: Elsevier Ltd
Category: Oncology
Indexation:
verifiedScopus / SJR
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
0,971
Q2
H-index
29
Acceptance rate
pie_chart
46%
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
NPD
Subscription
Non-OA path
NPD
Metrics
Scimago and CountryOfPapers database fields
Scopus / SJR
SJR Impact
0,971
H-index
29
Docs (year)
99
Docs 3y
486
Total refs
4879
Cites 3y
1440
Citable 3y
476
Cites/Doc 2y
2.49
Ref/Doc
49.28
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.